| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.18 | 0.03 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |